179 related articles for article (PubMed ID: 38194089)
1. Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images.
Kojima Y; Sawada S; Sakamoto Y
J Bone Miner Metab; 2024 Jan; 42(1):27-36. PubMed ID: 38194089
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Sakamoto Y; Sawada S; Kojima Y
Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
[TBL] [Abstract][Full Text] [Related]
3. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
4. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
[TBL] [Abstract][Full Text] [Related]
5. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw.
Ito K; Muraoka H; Hirahara N; Sawada E; Hirohata S; Otsuka K; Okada S; Kaneda T
Eur J Radiol; 2021 Dec; 145():110030. PubMed ID: 34798536
[TBL] [Abstract][Full Text] [Related]
7. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw.
Tadokoro Y; Hasegawa T; Takeda D; Murakami A; Yatagai N; Arimoro S; Iwata E; Saito I; Kusumoto J; Akashi M
Head Neck; 2024 Feb; 46(2):282-290. PubMed ID: 37962011
[TBL] [Abstract][Full Text] [Related]
9. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
10. Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery.
Soutome S; Yanamoto S; Sumi M; Hayashida S; Kojima Y; Sawada S; Rokutanda S; Iwai H; Saito T; Umeda M
J Bone Miner Metab; 2021 Mar; 39(2):302-310. PubMed ID: 33047190
[TBL] [Abstract][Full Text] [Related]
11. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
12. Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.
Morishita K; Soutome S; Otsuru M; Hayashida S; Murata M; Sasaki M; Takagi Y; Sumi M; Umeda M
Sci Rep; 2022 Jul; 12(1):11545. PubMed ID: 35799050
[TBL] [Abstract][Full Text] [Related]
13. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
Ogawa R; Ogura I
Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the clinical characteristics of patients with medication-related osteonecrosis of the jaw and osteoporosis or malignancy.
Feng Z; An J; He Y; Zhang Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):543-547. PubMed ID: 35668004
[TBL] [Abstract][Full Text] [Related]
16. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
[No Abstract] [Full Text] [Related]
18. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
19. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
20. A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients.
Jung S; Kim J; Park JH; Kim KY; Kim HJ; Park W
Sci Rep; 2022 May; 12(1):8641. PubMed ID: 35606457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]